Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simrit Parmar

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2016
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe PancytopeniaFleur M Aung, Benjamin Lichtiger, Gabriela Rondon, et al.
American Journal of Hematology|January 11, 2012
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaQaiser Bashir, Hassan Khan, Robert Z Orlowski, et al.
Transplantation and Cellular Therapy|March 30, 2021
Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple MyelomaSamer A Srour, Rima M Saliba, Qaiser Bashir, et al.
Bone Marrow Transplantation|April 14, 2015
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantationMarina Konopleva, Christopher B Benton, Peter F Thall, et al.
NEJM Evidence|May 28, 2024
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure SyndromesTapan M Kadia, Meixian Huang, Naveen Pemmaraju, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First RemissionGordon Glober, Jillian Gunther, Penny Fang, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
Blood|March 30, 2017
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantationLohith S Bachegowda, Rima M Saliba, Reshma Ramlal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized studySimrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesYago Nieto, Peter Thall, Ben Valdez, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2016
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe PancytopeniaFleur M Aung, Benjamin Lichtiger, Gabriela Rondon, et al.
American Journal of Hematology|January 11, 2012
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaQaiser Bashir, Hassan Khan, Robert Z Orlowski, et al.
Transplantation and Cellular Therapy|March 30, 2021
Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple MyelomaSamer A Srour, Rima M Saliba, Qaiser Bashir, et al.
Bone Marrow Transplantation|April 14, 2015
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantationMarina Konopleva, Christopher B Benton, Peter F Thall, et al.
NEJM Evidence|May 28, 2024
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure SyndromesTapan M Kadia, Meixian Huang, Naveen Pemmaraju, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First RemissionGordon Glober, Jillian Gunther, Penny Fang, et al.
Plos One|November 9, 2013
Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activityNina Shah, Beatriz Martin-Antonio, Hong Yang, et al.
Blood|March 30, 2017
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantationLohith S Bachegowda, Rima M Saliba, Reshma Ramlal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized studySimrit Parmar, Borje S Andersson, Daniel Couriel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesYago Nieto, Peter Thall, Ben Valdez, et al.
Pageof 12